| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8833678 | Journal of the American College of Surgeons | 2018 | 23 Pages |
Abstract
When combined with risk-appropriate genetic counseling, detection of VUS did not lead to excessive CPM in this cohort of triple-negative breast cancer patients. Furthermore, panel testing detected mutations in non-breast cancer-associated genes, which had significant implications on management and outcomes.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
Holly J. MD, Dharmesh MD, Ryan MS, Courtney MPH, Charis MD, PhD, Stephen R. MD, FACS,